Atlas Trials

Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate

Clinical trial NCT03659929 · COMPLETED

Trial details

NCT number
NCT03659929
Sponsor
Arbor Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Attention Deficit Hyperactivity Disorder
Start date
2018-09-18
Primary completion
2019-04-12
Enrollment
320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.